References

1. Canavan TP, Simhan HN, Caritis S. An evidence-based approach to the evaluation and treatment of premature rupture of membranes:Part I. Obstet Gynecol Surv.2004;59(9):669-77.
2. Dale PO, Tanbo T, Bendvold E, Moe N. Duration of the latency period in preterm premature rupture of the membranes: Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol.1989;30(3):257-62.
3. Tanya M, Medina.D, Ashley Hill._.Preterm Premature Rupture of Membranes: Diagnosis and Management. Am FamP hysician.2006 ;73(4):659-664.
4. Mercer BM, Arheart KL.Antimicrobial therapy in expectant management of preterm premature rupture of membranes. Lancet.1995;346:1271-9.
5. Egarter C, Leitich H, Karas H, Weiser F, Husslein P, Kaider A et al. Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: ametaanalysis. Am J Obstet Gynecol. 1996;174:589-97.
6. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of membranes.A randomised controlled trial. National Institute of Child Health and  Human Development  Maternal Fetal Medicine Units Network. JAMA 1997;278(12):989-95.
7. Khandelwal M, Chang E, Hansen C, Hunter K, Milcarek. Betamethasone dosing interval :12 or 24 hrsapart? A randomised, non inferiority open trial. Am J Obstet Gynecol.2012;206:201.
8. Haas DM, McCullough W, McNamara MF, Olsen C. The first 48 hours: Comparing 12-hour and 24-hour betamethasone dosing when preterm deliveries occur rapidly. J Matern Fetal Neonatal Med.2006 ;19(6):365-9.

Corresponding Author

Dr Pratibha Gupta

YS Parmar Govt. Medical College, Nahan